Provided by Tiger Fintech (Singapore) Pte. Ltd.

Instil Bio, Inc.

14.61
-2.0200-12.15%
Post-market: 14.00-0.6100-4.18%17:03 EDT
Volume:140.31K
Turnover:2.13M
Market Cap:95.34M
PE:-1.28
High:16.32
Open:15.02
Low:14.34
Close:16.63
Loading ...

Company Profile

Company Name:
Instil Bio, Inc.
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
14
Office Location:
3963 Maple Avenue,Suite 350,Dallas,Texas,United States
Zip Code:
75219
Fax:
- -
Introduction:
Instil Bio, Inc is a global, clinical-stage cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of cancer. We are building on the decades-long foundation of TIL efficacy in treating solid tumors, applying our cell therapy experience and TIL manufacturing platform to bring the promise of TIL therapy to patients in need. Instil Bio has research and cell therapy manufacturing facilities in Los Angeles, CA and Manchester, UK, with corporate offices in Dallas, TX.

Directors

Name
Position
Bronson Crouch
Chief Executive Officer and Chairman
Neil Gibson
Lead Independent Director
George Matcham
Director
Gwendolyn Binder
Director
Jack B. Nielsen
Director
Nimish Shah
Director
R. Kent McGaughy, Jr.
Director

Shareholders

Name
Position
Bronson Crouch
Chief Executive Officer and Chairman
Sandeep Laumas
Chief Financial Officer and Chief Business Officer
Vijay Chiruvolu
Chief Technical Officer
Zachary Roberts
Chief Medical Officer